Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 58162724 | 5816272 | 4 | F | 20050328 | 20160822 | 20050610 | 20160822 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-12974200 | BRISTOL MYERS SQUIBB | 0.00 | DY | F | Y | 2.55000 | KG | 20160822 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 58162724 | 5816272 | 1 | PS | REYATAZ | ATAZANAVIR SULFATE | 1 | Transplacental | 300 MG, QD | 71700 | MG | U | 21567 | 300 | MG | CAPSULE, HARD | QD | |||
| 58162724 | 5816272 | 2 | SS | VIDEX EC | DIDANOSINE | 1 | Transplacental | 250 MG, QD | U | 0 | 250 | MG | GASTRO-RESISTANT CAPSULE, HARD | QD | |||||
| 58162724 | 5816272 | 3 | SS | NORVIR | RITONAVIR | 1 | Transplacental | 100 MG, QD | 23900 | MG | U | 0 | 100 | MG | QD | ||||
| 58162724 | 5816272 | 4 | SS | EPIVIR | LAMIVUDINE | 1 | Transplacental | 300 MG, QD | U | 0 | 300 | MG | QD | ||||||
| 58162724 | 5816272 | 5 | SS | VIREAD | TENOFOVIR DISOPROXIL FUMARATE | 1 | Transplacental | UNK | U | 0 | |||||||||
| 58162724 | 5816272 | 6 | SS | RETROVIR | ZIDOVUDINE | 1 | Oral | 1.5 MG, QID | U | 0 | 1.5 | MG | QID | ||||||
| 58162724 | 5816272 | 7 | SS | RETROVIR | ZIDOVUDINE | 1 | Intravenous (not otherwise specified) | 1.65 MG/KG, BID | U | 0 | 1.65 | MG/KG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 58162724 | 5816272 | 1 | Product used for unknown indication |
| 58162724 | 5816272 | 2 | Product used for unknown indication |
| 58162724 | 5816272 | 3 | Product used for unknown indication |
| 58162724 | 5816272 | 4 | Product used for unknown indication |
| 58162724 | 5816272 | 5 | Product used for unknown indication |
| 58162724 | 5816272 | 6 | Product used for unknown indication |
| 58162724 | 5816272 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 58162724 | 5816272 | OT |
| 58162724 | 5816272 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 58162724 | 5816272 | Enterocolitis haemorrhagic | |
| 58162724 | 5816272 | Foetal exposure during pregnancy | |
| 58162724 | 5816272 | Hypoglycaemia | |
| 58162724 | 5816272 | Jaundice neonatal | |
| 58162724 | 5816272 | Premature baby |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 58162724 | 5816272 | 1 | 20040729 | 20050324 | 0 | |
| 58162724 | 5816272 | 2 | 200405 | 20050324 | 0 | |
| 58162724 | 5816272 | 3 | 20040729 | 20050324 | 0 | |
| 58162724 | 5816272 | 4 | 20041028 | 20050324 | 0 | |
| 58162724 | 5816272 | 5 | 20041028 | 0 | ||
| 58162724 | 5816272 | 6 | 20050328 | 0 | ||
| 58162724 | 5816272 | 7 | 200503 | 2005 | 0 |